Health Care & Life Sciences » Biotechnology | Global Blood Therapeutics Inc.

Global Blood Therapeutics Inc.

Global Blood Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
52.05 M
Public Float
44.65 M
Global Blood Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.41
Market Cap
$3.28 B
Shares Outstanding
56.41 M
Public Float
53.97 M

Profile

Address
171 Oyster Point Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.gbt.com
Updated 07/08/2019
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P.

Financials

View All
Created with Highcharts 5.0.14Global Blood Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.18 11618 11620 80720 80746 36046 36082 46882 468117 024117 024174 193174 193201320142015201620172018050k100k150k200k

Ted W. Love
President, Chief Executive Officer & Director
Wendy L. Yarno
Independent Director